EVALUATION OF ATRIAL FIBRILLATION MANAGEMENT AND CARDIOVASCULAR RISK PROFILE IN ATRIAL FIBRILLATION PATIENTS: CROSS-SECTIONAL SURVEY
G. Marinskis, G. Rackauskas, V. Zabiela, A. Baranauskas, D. Balkute, J. Alunderyte, A. Puodziukynas, T. Kazakevicius, V. Kviesulaitis, A. Aidietis
1. Centre of Cardiology and Angiology, Vilnius University Hospital Santariki? Klinikos, Vilnius; 2. Lithuania Hospital of Lithuanian University of Health Sciences Kauno Klinikos; 3. Department of Cardiology, Kaunas, Lithuania Vilnius University, Vilnius, Lithuania; 4. Lithuanian University of Health Sciences, Kaunas, Lithuania
Introduction: to describe the management of patients with atrial fibrillation (AF) in Lithuania.
Methods: this was a cross-sectional study of consecutive in - and outpatients with AF from November 2013 to May 2014. We collated clinical data of the most frequent risk factors, co - morbidities, complications and medical therapy. Stroke risk and bleeding risk were assessed using risk stratification tools (CHA2DS2-VASc and HAS-BLED).
Results: We enrolled 515 patients (mean age 70.7 years; 51.5% male). The most frequent type of AF was permanent type – 46.6%. Common comorbidities were hypertension 85.8%, heart failure 77.9% and coronary artery disease 51.8%. Amiodarone was the most common antiarrhythmic agent used in 14.6%. Oral anticoagulants (OACs) were used in 57.3 % overall, most often vitamin K antagonists 95.6%, while novel OACs being used in only 4.4%. INR within the therapeutic range (2-3) was in 19.2% of patients. Of the whole cohort, the mean CHA2DS2-VASc score was 3.87 ± 1.6 and the mean HAS-BLED was 2.25± 1.0.
Conclusions: Anticoagulation was underused in this population. Strategies need to be developed to improve prescription of anticoagulation treatment.
